Revenue Cycle

Supreme Court rules in favor of pharma in privacy case

Strategies for Health Care Compliance, October 1, 2011

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Strategies for Health Care Compliance.

Some hoped that the practice of buying data would be banned because many believe it's a privacy violation. Had the practice been outlawed, it would have made compliance officers' jobs a little easier because it could have prevented pharmaceutical representatives from using prescriber data to influence physicians' prescribing practices.

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Strategies for Health Care Compliance.

Most Popular